Early Lymph Node Metastasis May Predict Poor Prognosis in Soft Tissue Sarcoma

Int J Surg Oncol. 2019 Dec 12:2019:6708474. doi: 10.1155/2019/6708474. eCollection 2019.

Abstract

Background: Lymph node metastasis (LNM) is a relatively rare event in soft tissue sarcoma. An association between the timing of LNM detection and patient prognosis is presently unknown.

Patients and methods: We retrospectively analyzed the clinicopathological features of 33 patients with LNM between 2001 and 2015. Analysis of the timing of LNM diagnosis was grouped according to patients presenting LNM in either <8 months (the median time from primary tumor diagnosis to LNM) or ≥8 months after primary tumor diagnosis.

Results: A relationship between the primary tumor size and the timing of the LNM was not significantly found (Rs = 0.0088, p=0.96). Sixteen patients had an LNM detection duration of <8 months, and 17 patients had a duration of ≥8 months. The 5-year survival for patients with an LNM detection duration of <8 months and ≥8 months was 19% and 71%, respectively (p=0.0016). There were 19 patients with pulmonary metastases. Among them, there were 13 patients with a duration of primary tumor diagnosis to LNM of <8 months and 6 with a duration of ≥8 months (p=0.01).

Conclusion: Early LNM (<8 months) may predict poor prognosis in soft tissue sarcoma.

MeSH terms

  • Delayed Diagnosis
  • Female
  • Humans
  • Lung Neoplasms / secondary
  • Lymphatic Metastasis*
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Sarcoma / mortality*
  • Sarcoma / pathology*
  • Sarcoma / therapy
  • Soft Tissue Neoplasms / mortality*
  • Soft Tissue Neoplasms / pathology*
  • Soft Tissue Neoplasms / therapy
  • Survival Rate